Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Cancer Immunology, Immunotherapy : CII
Ramesh K RamanathanO J Finn

Abstract

MUC1 is a glycoprotein overexpressed in tumors as a hypoglycosylated form. A vaccine composed of a 100-amino acid peptide corresponding to five 20-amino acid long repeats, and SB-AS2 adjuvant, was tested in a phase I study for safety, toxicity, and ability to elicit or boost MUC1-specific immune responses. Patients with resected or locally advanced pancreatic cancer without prior chemotherapy or radiotherapy were eligible. Escalating doses of the peptide (100, 300, 1,000, and 3,000 mug) were admixed with SB-AS2 and administered intramuscularly every 3 weeks for three doses, in cohorts of four patients. Sixteen patients were enrolled. Common adverse effects were grade 1 flu-like symptoms, tenderness, and erythema at the injection site. Delayed-type hypersensitivity (DTH) sites showed few or no T cells prevaccination (Pre V), but increased T-cell infiltration postvaccination (Post V). There was an increase in the percentage of CD8(+) T cells in the peripheral blood Post V. An increase in total MUC1-specific antibody was seen in some patients, and several patients developed IgG antibody. Two of 15 resected pancreatic cancer patients are alive and disease free at follow-up of 32 and 61 months. MUC1 100mer peptide with SB-AS2 adjuva...Continue Reading

References

Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D L BarndO J Finn
Jun 1, 1995·Immunological Reviews·O J FinnS M Barratt-Boyes
Mar 1, 1997·Lancet·A Johnson
Mar 1, 1997·Immunology Today·J Taylor-Papadimitriou, O J Finn
Apr 5, 1997·Lancet·C Johnson
Feb 16, 2000·The American Journal of Tropical Medicine and Hygiene·J F DohertyJ Cohen
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E M HiltboldO J Finn
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E M JaffeeC J Yeo
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M SimonJ A Berzofsky
Sep 8, 2001·Journal of Mammary Gland Biology and Neoplasia·S J Gendler
Nov 22, 2001·Lancet·J P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
Jan 30, 2002·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael Thun

❮ Previous
Next ❯

Citations

Dec 5, 2008·Molecular Pharmaceutics·Welson W WangMavanur R Suresh
Aug 3, 2005·Nature Reviews. Cancer·Mark M Fuster, Jeffrey D Esko
Dec 11, 2008·Journal of Gastroenterology and Hepatology·Antonio M Morselli-Labate, Raffaele Pezzilli
Jul 10, 2010·Journal of Biomedicine & Biotechnology·Roberto Bei, Antonio Scardino
Sep 17, 2011·Clinical & Developmental Immunology·Shigeo KoidoHisao Tajiri
Jan 15, 2013·Journal of Amino Acids·Jyothi Thundimadathil
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James L GulleyJeffrey Schlom
Jul 12, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Uwe KarstenSteffen Goletz
Nov 16, 2006·International Archives of Allergy and Immunology·Sean O RyanOlivera J Finn
Apr 6, 2011·Immunotherapy·Lindzy F DodsonPeter Goedegebuure
Nov 16, 2013·Cancer Immunology, Immunotherapy : CII·Caroline JochemsKwong-Yok Tsang
Jun 21, 2014·Future Oncology·Meaghan L KhanMitesh J Borad
Jul 20, 2010·Immunotherapy·Richard E BeatsonJoy M Burchell
Mar 2, 2011·International Journal of Hematology·Adam J LinleyRobert C Rees
Jun 2, 2010·Cancer Immunology, Immunotherapy : CII·A HellerN A Giese
Feb 21, 2016·International Immunopharmacology·Boqi HuGuixiang Tai
Aug 25, 2005·Expert Review of Vaccines·Bruce Acres, Jean-Marc Limacher
Feb 17, 2011·Expert Review of Hematology·Gheath Alatrash, Jeffrey J Molldrem
Sep 5, 2008·Expert Review of Vaccines·Choon-Kit TangVasso Apostolopoulos
Jun 23, 2011·Expert Review of Vaccines·Janet Plate
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Peng H Tan, Amrit S Lota
Oct 17, 2006·Expert Opinion on Investigational Drugs·Florian EckelRoland M Schmid
Feb 17, 2009·Expert Opinion on Biological Therapy·Michael A MorseJanet M D Plate
Sep 25, 2012·Expert Opinion on Biological Therapy·Takashi Kimura, Olivera J Finn
Oct 11, 2015·Expert Opinion on Biological Therapy·Gareth RivallandPaul Mitchell
Feb 5, 2016·Journal of Cancer Research and Clinical Oncology·Elias KotteasKonstantinos Syrigos
Mar 1, 2016·Current Problems in Surgery·Mariam F EskanderJennifer F Tseng
Apr 21, 2010·Seminars in Immunology·Adam M Farkas, Olivera J Finn
Aug 30, 2008·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Han Hsi Wong, Nicholas R Lemoine
Nov 9, 2007·Biochimica Et Biophysica Acta·Mads Agervig Tarp, Henrik Clausen
Nov 21, 2007·Surgical Oncology Clinics of North America·Janet M D Plate
Aug 7, 2007·Seminars in Oncology·Mary F Mulcahy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.